Financial Snapshot

Revenue
$158.4M
TTM
Gross Margin
42.47%
TTM
Net Earnings
$15.71M
TTM
Current Assets
$164.4M
Q3 2024
Current Liabilities
$34.00M
Q3 2024
Current Ratio
483.6%
Q3 2024
Total Assets
$351.2M
Q3 2024
Total Liabilities
$95.94M
Q3 2024
Book Value
$255.3M
Q3 2024
Cash
$72.00M
Q3 2024
P/E
22.17
Nov 29, 2024 EST
Free Cash Flow
$31.82M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Revenue $142.5M $129.3M $103.6M $133.2M $127.2M $114.5M $102.8M $77.50M $69.90M $71.10M $70.60M $72.70M $59.50M $34.50M $14.50M $16.10M $12.60M $13.10M $11.50M $10.30M $7.000M
YoY Change 10.22% 24.81% -22.22% 4.72% 11.09% 11.38% 32.65% 10.87% -1.69% 0.71% -2.89% 22.18% 72.46% 137.93% -9.94% 27.78% -3.82% 13.91% 11.65% 47.14%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Revenue $142.5M $129.3M $103.6M $133.2M $127.2M $114.5M $102.8M $77.50M $69.90M $71.10M $70.60M $72.70M $59.50M $34.50M $14.50M $16.10M $12.60M $13.10M $11.50M $10.30M $7.000M
Cost Of Revenue $87.03M $82.60M $73.30M $85.70M $77.50M $73.00M $70.70M $56.10M $54.10M $56.00M $44.20M $50.00M $42.80M $28.70M $15.30M $16.00M $9.700M $10.10M $9.100M $8.000M $5.700M
Gross Profit $55.49M $46.70M $30.33M $47.55M $49.70M $41.50M $32.10M $21.40M $15.80M $15.00M $26.40M $22.70M $16.70M $5.800M -$800.0K $100.0K $3.000M $3.100M $2.400M $2.300M $1.400M
Gross Profit Margin 38.94% 36.12% 29.27% 35.7% 39.07% 36.24% 31.23% 27.61% 22.6% 21.1% 37.39% 31.22% 28.07% 16.81% -5.52% 0.62% 23.81% 23.66% 20.87% 22.33% 20.0%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Selling, General & Admin $29.54M $1.807M $265.0K $12.80M $11.50M $12.00M $9.900M $10.20M $10.00M $9.500M $6.300M $7.100M $6.400M $4.500M $5.000M $3.600M $3.000M $2.400M $2.000M $1.400M
YoY Change 1534.7% 581.89% 11.3% -4.17% 21.21% -2.94% 2.0% 5.26% 50.79% -11.27% 10.94% 42.22% -10.0% 38.89% 20.0% 25.0% 20.0% 42.86%
% of Gross Profit 53.23% 3.87% 0.87% 25.75% 27.71% 37.38% 46.26% 64.56% 66.67% 35.98% 27.75% 42.51% 110.34% 5000.0% 120.0% 96.77% 100.0% 86.96% 100.0%
Research & Development $13.93M $13.17M $11.36M $13.61M $12.40M $9.700M $12.00M $16.20M $16.50M $16.00M $12.70M $11.80M $11.70M $9.300M $8.600M $13.10M $10.80M $4.100M $2.800M $2.400M $2.500M
YoY Change 5.78% 15.98% -16.55% 9.75% 27.84% -19.17% -25.93% -1.82% 3.13% 25.98% 7.63% 0.85% 25.81% 8.14% -34.35% 21.3% 163.41% 46.43% 16.67% -4.0%
% of Gross Profit 25.11% 28.2% 37.45% 28.62% 24.95% 23.37% 37.38% 75.7% 104.43% 106.67% 48.11% 51.98% 70.06% 160.34% 13100.0% 360.0% 132.26% 116.67% 104.35% 178.57%
Depreciation & Amortization $12.71M $12.16M $5.610M $4.900M $4.520M $3.700M $3.520M $3.500M $3.230M $2.790M $3.000M $3.040M $3.040M $2.640M $2.400M $2.500M $2.000M $1.380M $1.000M $950.0K $890.0K
YoY Change 4.56% 116.76% 14.49% 8.41% 22.16% 5.11% 0.57% 8.36% 15.77% -7.0% -1.32% 0.0% 15.15% 10.0% -4.0% 25.0% 44.93% 38.0% 5.26% 6.74%
% of Gross Profit 22.91% 26.04% 18.5% 10.3% 9.09% 8.92% 10.97% 16.36% 20.44% 18.6% 11.36% 13.39% 18.2% 45.52% 2500.0% 66.67% 44.52% 41.67% 41.3% 63.57%
Operating Expenses $13.93M $14.98M $11.62M $13.61M $26.90M $22.20M $24.70M $26.90M $27.20M $26.50M $22.70M $18.40M $19.10M $16.00M $15.00M $18.10M $18.20M $7.100M $5.200M $4.400M $3.900M
YoY Change -6.98% 28.88% -14.6% -49.41% 21.17% -10.12% -8.18% -1.1% 2.64% 16.74% 23.37% -3.66% 19.38% 6.67% -17.13% -0.55% 156.34% 36.54% 18.18% 12.82%
Operating Profit $41.56M $31.72M $18.71M $33.94M $22.80M $19.30M $7.400M -$5.500M -$11.40M -$11.50M $3.700M $4.300M -$2.400M -$10.20M -$15.80M -$18.00M -$15.20M -$4.000M -$2.800M -$2.100M -$2.500M
YoY Change 31.0% 69.59% -44.89% 48.87% 18.13% 160.81% -234.55% -51.75% -0.87% -410.81% -13.95% -279.17% -76.47% -35.44% -12.22% 18.42% 280.0% 42.86% 33.33% -16.0%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Interest Expense -$655.0K -$500.0K -$1.200M -$800.0K $200.0K $1.100M -$300.0K $500.0K $400.0K -$1.600M -$3.200M -$2.800M -$1.700M -$3.500M -$3.600M $5.100M $0.00 -$200.0K -$400.0K -$300.0K
YoY Change 31.0% -58.33% 50.0% -500.0% -81.82% -466.67% -160.0% 25.0% -125.0% -50.0% 14.29% 64.71% -51.43% -2.78% -170.59% -100.0% -50.0% 33.33%
% of Operating Profit -1.58% -1.58% -6.42% -2.36% 0.88% 5.7% -4.05% -86.49% -65.12%
Other Income/Expense, Net -$980.0K -$6.300M $0.00 $100.0K $0.00 -$200.0K -$100.0K -$100.0K -$600.0K $500.0K -$700.0K -$1.800M -$200.0K -$6.200M $1.300M $4.200M $4.000M $300.0K
YoY Change -84.44% -100.0% 100.0% 0.0% -83.33% -220.0% -171.43% -61.11% 800.0% -96.77% -576.92% -69.05% 5.0% 1233.33%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Pretax Income $8.429M -$2.300M -$1.900M $18.60M $23.00M $20.30M $7.200M -$5.000M -$11.30M -$13.20M $500.0K $800.0K -$3.700M -$14.40M -$21.30M -$13.20M -$21.50M -$2.900M $1.000M $1.600M -$2.200M
YoY Change -466.48% 21.05% -110.22% -19.13% 13.3% 181.94% -244.0% -55.75% -14.39% -2740.0% -37.5% -121.62% -74.31% -32.39% 61.36% -38.6% 641.38% -390.0% -37.5% -172.73%
Income Tax $145.0K $100.0K $300.0K $1.400M $700.0K -$2.000M $300.0K $1.700M $0.00 $100.0K $0.00 $500.0K $0.00 $0.00 $0.00 $0.00 $0.00 $100.0K $0.00 $0.00 $0.00
% Of Pretax Income 1.72% 7.53% 3.04% -9.85% 4.17% 0.0% 62.5% 0.0% 0.0%
Net Earnings $8.284M -$2.321M -$2.230M $17.14M $22.30M $22.30M $6.900M -$6.700M -$11.30M -$13.20M $400.0K $300.0K -$3.700M -$14.40M -$21.30M -$13.20M -$21.50M -$3.000M $1.000M $1.600M -$2.200M
YoY Change -456.92% 4.08% -113.01% -23.14% 0.0% 223.19% -202.99% -40.71% -14.39% -3400.0% 33.33% -108.11% -74.31% -32.39% 61.36% -38.6% 616.67% -400.0% -37.5% -172.73%
Net Earnings / Revenue 5.81% -1.8% -2.15% 12.87% 17.53% 19.48% 6.71% -8.65% -16.17% -18.57% 0.57% 0.41% -6.22% -41.74% -146.9% -81.99% -170.63% -22.9% 8.7% 15.53% -31.43%
Basic Earnings Per Share
Diluted Earnings Per Share $0.15 -$0.05 -$0.05 $0.38 $0.55 $0.55 $0.18 -$0.18 -$0.31 -$0.37 $0.01 $0.01 -$0.13 -$0.54 -$1.06 -$1.00 -$2.05 -$0.32 $0.11 $0.17 -$0.24

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Cash & Short-Term Investments $55.64M $34.30M $18.60M $109.3M $73.90M $50.60M $43.00M $28.60M $28.30M $51.90M $74.20M $33.80M $41.20M $46.40M $30.90M $13.30M $3.900M $8.600M $5.200M $400.0K
YoY Change 62.22% 84.41% -82.98% 47.9% 46.05% 17.67% 50.35% 1.06% -45.47% -30.05% 119.53% -17.96% -11.21% 50.16% 132.33% 241.03% -54.65% 65.38% 1200.0%
Cash & Equivalents $15.01M $2.800M $3.200M $50.10M $17.10M $100.0K $100.0K $100.0K $100.0K $6.200M $19.00M $12.70M $24.40M $2.700M $30.40M $13.30M $3.900M $8.600M $5.200M $400.0K
Short-Term Investments $0.00 $39.10M $31.20M $32.50M $30.30M $18.70M $23.30M $37.40M $15.10M $16.90M $16.80M $43.70M $500.0K
Other Short-Term Assets $4.554M $3.900M $4.100M $2.500M $1.200M $1.100M $800.0K $1.100M $900.0K $1.100M $1.400M $1.000M $1.500M $200.0K
YoY Change 16.77% -4.88% 64.0% 108.33% 9.09% 37.5% -27.27% 22.22% -18.18% -21.43% 40.0% -33.33% 650.0%
Inventory $88.48M $72.50M $71.80M $43.00M $43.20M $29.30M $21.10M $25.60M $26.30M $25.40M $21.90M $20.50M $15.30M $10.70M $8.100M $8.100M $5.700M $6.400M $6.300M $3.400M
Prepaid Expenses
Receivables $19.92M $27.70M $35.30M $22.30M $23.30M $27.90M $30.70M $19.80M $23.10M $17.50M $17.90M $13.90M $7.100M $12.90M $4.000M $3.400M $5.000M $5.000M $4.300M $2.800M
Other Receivables $1.366M $700.0K $300.0K $800.0K $1.900M $2.000M $1.300M $2.000M $1.900M $1.200M $2.300M $600.0K $2.000M $1.700M $1.400M $900.0K $2.100M $2.200M $300.0K $400.0K
Total Short-Term Assets $170.0M $139.0M $130.0M $177.9M $143.6M $110.9M $96.90M $77.10M $80.60M $97.20M $117.7M $69.80M $67.10M $72.00M $44.50M $25.70M $16.70M $22.20M $16.10M $7.000M
YoY Change 22.27% 6.92% -26.93% 23.89% 29.49% 14.45% 25.68% -4.34% -17.08% -17.42% 68.62% 4.02% -6.81% 61.8% 73.15% 53.89% -24.77% 37.89% 130.0%
Property, Plant & Equipment $35.99M $28.70M $29.40M $29.10M $28.60M $25.00M $25.20M $22.20M $21.30M $21.80M $21.40M $18.80M $17.40M $19.90M $17.70M $14.30M $12.70M $8.200M $5.300M $5.300M
YoY Change 25.38% -2.38% 1.03% 1.75% 14.4% -0.79% 13.51% 4.23% -2.29% 1.87% 13.83% 8.05% -12.56% 12.43% 23.78% 12.6% 54.88% 54.72% 0.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $9.005M $7.600M $5.600M $2.100M $1.400M $2.100M $0.00 $200.0K $600.0K $300.0K $500.0K $2.000M $3.200M $1.400M $0.00 $0.00
YoY Change 18.49% 35.71% 166.67% 50.0% -33.33% -100.0% -66.67% 100.0% -40.0% -75.0% -37.5% 128.57%
Total Long-Term Assets $184.9M $183.4M $188.7M $32.80M $30.20M $27.20M $25.20M $22.60M $21.40M $21.90M $21.70M $19.30M $18.00M $20.20M $18.40M $16.40M $16.00M $9.700M $5.200M $5.200M
YoY Change 0.84% -2.81% 475.3% 8.61% 11.03% 7.94% 11.5% 5.61% -2.28% 0.92% 12.44% 7.22% -10.89% 9.78% 12.2% 2.5% 64.95% 86.54% 0.0%
Total Assets $354.9M $322.4M $318.7M $210.7M $173.8M $138.1M $122.1M $99.70M $102.0M $119.1M $139.4M $89.10M $85.10M $92.20M $62.90M $42.10M $32.70M $31.90M $21.30M $12.20M
YoY Change
Accounts Payable $24.80M $32.90M $25.10M $16.10M $24.80M $17.30M $18.00M $16.30M $16.90M $16.50M $14.10M $12.20M $12.50M $12.00M $6.000M $4.900M $4.400M $4.400M $2.900M $2.200M
YoY Change -24.61% 31.08% 55.9% -35.08% 43.35% -3.89% 10.43% -3.55% 2.42% 17.02% 15.57% -2.4% 4.17% 100.0% 22.45% 11.36% 0.0% 51.72% 31.82%
Accrued Expenses $8.084M $7.300M $6.900M $7.300M $5.800M $5.200M $5.800M $5.600M $4.100M $4.000M $4.300M $3.400M
YoY Change 10.74% 5.8% -5.48% 25.86% 11.54% -10.34% 3.57% 36.59% 2.5% -6.98% 26.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.384M $5.500M $3.800M $1.300M $1.500M $600.0K $600.0K $400.0K $0.00 $7.500M $8.700M $5.400M $0.00 $0.00 $100.0K $1.500M $4.600M $700.0K $500.0K $600.0K
YoY Change -74.84% 44.74% 192.31% -13.33% 150.0% 0.0% 50.0% -100.0% -13.79% 61.11% -100.0% -93.33% -67.39% 557.14% 40.0% -16.67%
Total Short-Term Liabilities $49.59M $75.70M $54.10M $25.00M $32.70M $23.60M $29.40M $27.20M $22.90M $31.00M $32.60M $29.20M $22.90M $20.00M $9.100M $9.100M $11.10M $6.800M $5.900M $5.600M
YoY Change -34.49% 39.93% 116.4% -23.55% 38.56% -19.73% 8.09% 18.78% -26.13% -4.91% 11.64% 27.51% 14.5% 119.78% 0.0% -18.02% 63.24% 15.25% 5.36%
Long-Term Debt $7.438M $15.10M $20.60M $3.600M $4.200M $700.0K $1.400M $1.400M $200.0K $0.00 $7.500M $18.70M $22.40M $23.30M $20.90M $18.90M $3.100M $2.900M $2.800M $4.000M
YoY Change -50.74% -26.7% 472.22% -14.29% 500.0% -50.0% 0.0% 600.0% -100.0% -59.89% -16.52% -3.86% 11.48% 10.58% 509.68% 6.9% 3.57% -30.0%
Other Long-Term Liabilities $53.86M $55.50M $67.20M $3.400M $1.500M $1.500M $1.900M $4.400M $6.400M $7.700M $9.300M $12.80M $17.20M $22.20M $2.700M $1.400M $6.900M $400.0K $400.0K $1.000M
YoY Change -2.96% -17.41% 1876.47% 126.67% 0.0% -21.05% -56.82% -31.25% -16.88% -17.2% -27.34% -25.58% -22.52% 722.22% 92.86% -79.71% 1625.0% 0.0% -60.0%
Total Long-Term Liabilities $61.29M $70.60M $87.80M $7.000M $5.700M $2.200M $3.300M $5.800M $6.600M $7.700M $16.80M $31.50M $39.60M $45.50M $23.60M $20.30M $10.00M $3.300M $3.200M $5.000M
YoY Change -13.18% -19.59% 1154.29% 22.81% 159.09% -33.33% -43.1% -12.12% -14.29% -54.17% -46.67% -20.45% -12.97% 92.8% 16.26% 103.0% 203.03% 3.13% -36.0%
Total Liabilities $110.9M $146.4M $141.8M $32.00M $38.50M $25.70M $32.60M $33.00M $29.50M $38.70M $49.40M $60.70M $62.50M $65.50M $32.70M $29.50M $21.10M $10.20M $9.100M $10.60M
YoY Change -24.26% 3.24% 343.13% -16.88% 49.81% -21.17% -1.21% 11.86% -23.77% -21.66% -18.62% -2.88% -4.58% 100.31% 10.85% 39.81% 106.86% 12.09% -14.15%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $348.36 Million

About KAMADA LTD

Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Industry: Pharmaceutical Preparations Peers: Enlivex Therapeutics Ltd. CollPlant Biotechnologies Ltd Gamida Cell Ltd. UroGen Pharma Ltd.